Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

Blood (2018) 132 (23): 2456–2464.

https://doi.org/10.1182/blood-2018-06-858613

Published: 2018

Includes: Supplemental data

Journal Articles

Comparison of MRD Detection By MFC, NGS and PET-CT in Patients at Different Treatment Stages for Multiple Myeloma

Sandra Susanibar, MD, Victoria Carlton, PhD, Sharmilan Thanendrarajan, MD, Meera Mohan, MD, Pankaj Mathur, MD, Shadiqul Hoque, MD, Muthukumar Radhakrishnan, MD, Frits van Rhee, MD PhD, Maurizio Zangari, MD, Faith E Davies, MD, Katherine A. Kong, PhD, Gareth J Morgan, MD PhD, Daisy V. Alapat, MD, Carolina Schinke, MD

Blood (2016) 128 (22): 377.

https://doi.org/10.1182/blood.V128.22.377.377

Published: 2016

Journal Articles

Next-Generation Sequencing Based Minimal Residual Disease Assessment in Peripheral Blood RNA from Multiple Myeloma Patients

Jeffrey L. Wolf, MD, Katherine A. Kong, PhD, Jenai Wilmoth, RN, Joshua Bayes, Amy Marsala, ANP,MPH, Victoria Carlton, PhD, Aaron Logan, MDPhD, Thomas G. Martin, III, MD

Blood (2016) 128 (22): 3286.

https://doi.org/10.1182/blood.V128.22.3286.3286

Published: 2016

Journal Articles

Evaluation of Minimal Residual Disease (MRD) in Relapsed/Refractory Multiple Myeloma (RRMM) Patients Treated with Daratumumab in Combination with Lenalidomide Plus Dexamethasone or Bortezomib Plus Dexamethasone

Hervé Avet-Loiseau, Tineke Casneuf, Christopher Chiu, PhD, Jacob P. Laubach, MD, Je-Jung Lee, Philippe Moreau, Torben Plesner, Professor, Hareth Nahi, Nushmia Z Khokhar, Ming Qi, Jordan Schecter, Victoria Carlton, PhD, Xiang Qin, Kevin Liu, Kaida Wu, MD PhD, Sen H. Zhuang, MD, PhD, Tahamtan Ahmadi, MD, A. Kate Sasser, PhD, Jesús San-Miguel, MD PhD

Blood (2016) 128 (22): 246.

https://doi.org/10.1182/blood.V128.22.246.246

Published: 2016

Journal Articles

A Novel Evolutionary Pattern Revealed Using Deep Sequencing of Immunoglobulin Loci at Diagnosis and over the Course of Treatment in Multiple Myeloma Patients

Nikhil C. Munshi, MD, Joaquin Martinez-Lopez, Victoria Carlton, PhD, Stephanie Minvielle, Yu-Tzu Tai, PhD, Mariateresa Fulciniti, PhD, Mehmet K. Samur, PhD, Paul G. Richardson, MD, Michel Attal, Philippe Moreau, Florence Magrangeas, Kenneth C. Anderson, MD, Malek Faham, MD PhD, Herve Avet-Loiseau, MD PhD

Blood (2016) 128 (22): 238.

https://doi.org/10.1182/blood.V128.22.238.238

Published: 2016

Journal Articles

Next Generation Sequencing (NGS) Based Minimal Residual Disease (MRD) Testing Is Highly Predictive of Overall and Progression Free Survival in the Total Therapy Trials and Shows Different Prognostic Implications in High Vs Standard Risk Multiple Myeloma

Blood (2016) 128 (22): 2064.

https://doi.org/10.1182/blood.V128.22.2064.2064

Published: 2016

Journal Articles

Antigen Presentation Profiling Reveals T-Cell Recognition of Lymphoma Immunoglobulin Neoantigens

Blood (2016) 128 (22): 915.

https://doi.org/10.1182/blood.V128.22.915.915

Published: 2016

Journal Articles

Assessment of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia Patients Using Next-Generation Sequencing Method

John K Choi, Sima Jeha, Jianbiao Zheng, Victoria Carlton, Malek Faham, MD PhD, Ching-Hon Pui, MD

Blood (2015) 126 (23): 4981.

https://doi.org/10.1182/blood.V126.23.4981.4981

Published: 2015

Journal Articles

Quantitative Assessment of Circulating Clonal IG-VDJ Sequences in Plasma of Follicular Lymphoma at Diagnosis Is Highly Predictive of Progression Free Survival (PFS)

Clémentine Sarkozy, MD, Sarah Huet, PharmD, PhD, Victoria Carlton, Alain Delmer, MD PhD, Fabrice Jardin, Marie-Helene Delfau-Larue, MD PhD, Malek Faham, Gilles Salles, MD PhD

Blood (2015) 126 (23): 2675.

https://doi.org/10.1182/blood.V126.23.2675.2675

Published: 2015

Journal Articles

Next-Generation Sequencing Reveals Clonal Evolution at the Immunoglobulin Loci in Chronic Lymphocytic Leukemia

Jennifer R. Brown, Stacey M. Fernandes, Siddha Kasar, Kevin Hoang, Martin Moorhead, PhD, Victoria Carlton, Malek Faham, David B. Miklos, Aaron C. Logan

Blood (2014) 124 (21): 3302.

https://doi.org/10.1182/blood.V124.21.3302.3302

Published: 2014

Journal Articles

Sequence Level Analysis of Hodgkin Lymphoma Clonotypes Detected in Peripheral Blood Using a Next-Generation Sequencing Approach

Yasuhiro Oki, MD, Sattva S. Neelapu, Michelle Fanale, Larry W. Kwak, MD PhD, Luis Fayad, MD, Maria Alma Rodriguez, Michael Wallace, Mark Klinger, Victoria Carlton, Katherine A Kong, Malek Faham, Anas Younes

Blood (2014) 124 (21): 1610.

https://doi.org/10.1182/blood.V124.21.1610.1610

Published: 2014

Journal Articles

Assessment of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia Patients Using Next-Generation Sequencing Method

John K. Choi, MD, Sima Jeha, MD, Li Weng, Victoria Carlton, Malek Faham, Ching-Hon Pui, MD

Blood (2014) 124 (21): 5343.

https://doi.org/10.1182/blood.V124.21.5343.5343

Published: 2014

Journal Articles

Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance)

Greg Malnassy, MS, Susan Geyer, PhD, Noreen Fulton, B.S., Greg Koval, B.S., Donna Niedzwiecki, PhD, Victoria Carlton, PhD, Li Weng, PhD, Lawrence D. Kaplan, MD, Guido Marcucci, MD, Lloyd E Damon, MD, Richard A. Larson, MD, Richard M. Stone, MD, Bruce D. Cheson, M.D., Malek Faham, MD, PhD, Wendy Stock, M.D.

Blood (2013) 122 (21): 2547.

https://doi.org/10.1182/blood.V122.21.2547.2547

Published: 2013

Journal Articles

Minimal Residual Disease Monitoring In Acute Lymphoblastic Leukemia Patients Using Immune Receptor Sequencing

Malek Faham, MD, PhD, Maddalena Paganin, Giulia Fabbri, Elisa Magrin, Emanuela Giarin, Valentino Conter, Maurizio Arico, MD, Francois Pepin, Victoria Carlton, PhD, Giuseppe Basso

Blood (2013) 122 (21): 1381.

https://doi.org/10.1182/blood.V122.21.1381.1381

Published: 2013

Journal Articles

Deep Sequencing Reveals Oligoclonality At The Immunoglobulin Locus In Multiple Myeloma Patients

Joaquin Martinez-Lopez, MD, PhD, Mariateresa Fulciniti, PhD, Santiago Barrio, PhD, Victoria Carlton, PhD, Martin Moorhead, PhD, Juan Jose Lahuerta, MD, Kenneth C. Anderson, MD, Florence Magrangeas, Stephane Minvielle, PhD, Herve Avet-loiseau, Malek Faham, MD, PhD, Nikhil C. Munshi, MD

Blood (2013) 122 (21): 401.

https://doi.org/10.1182/blood.V122.21.401.401

Published: 2013

Journal Articles

Detection Of Classical Hodgkin Lymphoma In Peripheral Blood Using High-Throughput Sequencing Assay

Yasuhiro Oki, MD, Sattva S. Neelapu, MD, Michelle A. Fanale, MD, Larry W. Kwak, MD, PhD, Luis E Fayad, Alma Rodriguez, M.D., Michael Wallace, MD, Victoria Carlton, PhD, Katherine Kong, Malek Faham, MD, PhD, Anas Younes, MD

Blood (2013) 122 (21): 627.

https://doi.org/10.1182/blood.V122.21.627.627

Published: 2013

Journal Articles

Next-Generation Sequencing and Real-Time Quantitative PCR For Quantification Of Low-Level Minimal Residual Disease In Acute Lymphoblastic Leukemia Of Adults

Monika Brüggemann, MD, Matthias Ritgen, MD, Marco Ladetto, Francois Pepin, Heiko Trautmann, Victoria Carlton, PhD, Dieter Hoelzer, MD, Nicola Gökbuget, MD, Michael Kneba, MD, Malek Faham, MD, PhD, Christiane Pott, M.D. Ph.D.

Blood (2013) 122 (21): 351.

https://doi.org/10.1182/blood.V122.21.351.351

Published: 2013

Journal Articles

Clonosight: A Standardized Clinical Assay for Measurement of Minimal Residual Disease in Leukemias and Lymphomas

Thomas D. Willis, PhD, Tom Asbury, PhD, Victoria Carlton, PhD, Lei Fang, PhD, Mark Klinger, PhD, Martin Moorhead, PhD, Kaliprasad Pothuraju, MS, Li Weng, PhD, Jianbiao Zheng, PhD, Malek Faham, MD, PhD

Blood (2012) 120 (21): 1434.

https://doi.org/10.1182/blood.V120.21.1434.1434

Published: 2012

Journal Articles

Deep Sequencing Approach for Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia

Malek Faham, MD, PhD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Victoria Carlton, Patricia Lee Stow, BA, MS, Elaine Coustan-Smith, MS, Ching-Hon Pui, MD, Dario Campana, MD, PhD

Blood (2012) 120 (21): 1388.

https://doi.org/10.1182/blood.V120.21.1388.1388

Published: 2012

Journal Articles

Minimal Residual Disease Quantification in Acute Lymphoblastic Leukemia Using High-Throughput Sequencing of Multiple Immunoreceptor Genes Predicts Relapse and Survival After Allogeneic Hematopoietic Cell Transplantation.

Aaron C. Logan, MD, PhD, Nikita Vashi, BS, Malek Faham, MD, PhD, Victoria Carlton, PhD, Ismael Buno, PhD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Mark Klinger, PhD, Tom Willis, PhD, Bing Zhang, MD, Amna Waqar, BS, James L. Zehnder, David B Miklos, MD, PhD

Blood (2012) 120 (21): 2512.

https://doi.org/10.1182/blood.V120.21.2512.2512

Published: 2012

NARROW

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

Comparison of MRD Detection By MFC, NGS and PET-CT in Patients at Different Treatment Stages for Multiple Myeloma

Next-Generation Sequencing Based Minimal Residual Disease Assessment in Peripheral Blood RNA from Multiple Myeloma Patients

Evaluation of Minimal Residual Disease (MRD) in Relapsed/Refractory Multiple Myeloma (RRMM) Patients Treated with Daratumumab in Combination with Lenalidomide Plus Dexamethasone or Bortezomib Plus Dexamethasone

A Novel Evolutionary Pattern Revealed Using Deep Sequencing of Immunoglobulin Loci at Diagnosis and over the Course of Treatment in Multiple Myeloma Patients

Next Generation Sequencing (NGS) Based Minimal Residual Disease (MRD) Testing Is Highly Predictive of Overall and Progression Free Survival in the Total Therapy Trials and Shows Different Prognostic Implications in High Vs Standard Risk Multiple Myeloma

Antigen Presentation Profiling Reveals T-Cell Recognition of Lymphoma Immunoglobulin Neoantigens

Assessment of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia Patients Using Next-Generation Sequencing Method

Quantitative Assessment of Circulating Clonal IG-VDJ Sequences in Plasma of Follicular Lymphoma at Diagnosis Is Highly Predictive of Progression Free Survival (PFS)

Next-Generation Sequencing Reveals Clonal Evolution at the Immunoglobulin Loci in Chronic Lymphocytic Leukemia

Sequence Level Analysis of Hodgkin Lymphoma Clonotypes Detected in Peripheral Blood Using a Next-Generation Sequencing Approach

Assessment of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia Patients Using Next-Generation Sequencing Method

Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance)

Minimal Residual Disease Monitoring In Acute Lymphoblastic Leukemia Patients Using Immune Receptor Sequencing

Deep Sequencing Reveals Oligoclonality At The Immunoglobulin Locus In Multiple Myeloma Patients

Detection Of Classical Hodgkin Lymphoma In Peripheral Blood Using High-Throughput Sequencing Assay

Next-Generation Sequencing and Real-Time Quantitative PCR For Quantification Of Low-Level Minimal Residual Disease In Acute Lymphoblastic Leukemia Of Adults

Clonosight: A Standardized Clinical Assay for Measurement of Minimal Residual Disease in Leukemias and Lymphomas

Deep Sequencing Approach for Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia

Minimal Residual Disease Quantification in Acute Lymphoblastic Leukemia Using High-Throughput Sequencing of Multiple Immunoreceptor Genes Predicts Relapse and Survival After Allogeneic Hematopoietic Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only